Skinvisible

Skinvisible Fixed Asset Turnover

The Fixed Asset Turnover of Skinvisible (SKVI) as of Nov 4, 2026 is 587.69. In the previous year, Fixed Asset Turnover was 1,752.16 — a change of -66.46% (lower).

Fixed Asset Turnover

587.69

YoY

-66.46%

Last updated:

Fixed Asset Turnover of Skinvisible is 2018 587.69 . Fixed Asset Turnover of Skinvisible was 2017 1,752.16 . It decreases by -66.46% lower compared to the previous year.

The Skinvisible Fixed Asset Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Fixed Asset Turnover
Date
Fixed Asset Turnover
Jan 1, 2014
16.77 USD
Jan 1, 2015
103.03 USD
Jan 1, 2016
159.43 USD
Jan 1, 2017
1,752.16 USD
Jan 1, 2018
587.69 USD
The Skinvisible Fixed Asset Turnover history
YEARFixed Asset TurnoverYoY
587.69-66.46%
1,752.16+999.02%
159.43+54.74%
103.03+514.35%
16.77—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Skinvisible Stock analysis

What does Skinvisible do? Skinvisible Inc develops and patents the Invisicare polymer delivery system, which enhances the delivery of active ingredients in topical skin care products. The company has formulated over forty topical skin products using Invisicare, with Pivotal being the patented technology that enables extended duration of active ingredients on the skin. Invisicare specifically carries water-insoluble and certain cationic active ingredients in water-based products without alcohol, silicones, waxes, or organic solvents. The firm's revenue comes from licensing the Invisicare technology to partners who develop and sell skin care products incorporating this delivery system. Skinvisible Inc's primary customers are pharmaceutical and cosmetic companies seeking to improve the efficacy of their topical skin care formulations. These companies purchase the Invisicare technology to integrate into their own product lines, leveraging the extended delivery duration and compatibility with water-based formulations. The company does not sell end-user products but focuses on technology licensing for partners who manufacture and market the final skin care products. The business model relies on the patent protection of Invisicare, which allows Skinvisible to generate revenue through licensing agreements. Partners pay for the right to use the technology in their products, with the company's focus on developing and protecting the polymer delivery system as its core asset. The firm's product portfolio includes over forty topical skin products developed using Invisicare, but these are not sold directly by Skinvisible Inc. Skinvisible is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Skinvisible stock

Fixed Asset Turnover of Skinvisible is 587.69 in 2018.

Fixed Asset Turnover of Skinvisible changed from 1,752.16 to 587.69, representing a -66.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Fixed Asset Turnover Skinvisible since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's Skinvisible with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Skinvisible

All Key Metrics — Skinvisible